Journal article
Bcl-2 family proteins as therapeutic targets
PE Czabotar, G Lessene
Current Pharmaceutical Design | BENTHAM SCIENCE PUBL LTD | Published : 2010
Abstract
The mitochondrion provides the stage for the interplay of molecular interactions that regulate apoptosis via the intrinsic pathway. The release of apoptogenic factors from this compartment constitutes a critical juncture in this apoptotic pathway. Regulation of the integrity of the outer mitochondrial membrane (OMM) is the task of the Bcl-2 family of proteins. A network of interactions between the various subgroups of the family decides the apoptotic fate of a cell and, as such, an imbalance within this network can lead to a variety of disease states. In particular, over-expression of pro-survival Bcl-2 family proteins is a hallmark of many cancers. Here we discuss recent advances in targeti..
View full abstractGrants
Funding Acknowledgements
We thank our colleagues at the Walter and Eliza Hall Institute for helpful discussions, in particular Prof. Peter Colman and Dr. David Huang. Work in our laboratory is supported by grants and fellowships from the Australian NHMRC and ARC.